UNCY
Unicycive Therapeutics Inc
4.10$
+1.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | -100.0% | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +100.0% | +0.0% | -50.0% | +100.0% | +2,150.0% | +73.3% | +1.3% | +3.8% | +246.3% | – | – | +130.9% | -52.5% | +2.2% | – | – | +39.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.2% | – | -111.6% | – | – | – | – | – | – | -147.5% | – | – | – | – | – | – | |
| – | +0.0% | +62.8% | +100.0% | -60.6% | +23.0% | +67.0% | +25.7% | +17.8% | +9.6% | +665.9% | -64.0% | +42.0% | -3.8% | +158.2% | -20.0% | -21.1% | -25.2% | +48.7% | +25.5% | +60.9% | -28.5% | -37.4% | +73.7% | -58.9% | -19.4% | +69.4% | -24.1% | -28.6% | +73.5% | – | |
| – | +0.0% | +6.5% | +10.9% | -40.3% | -20.6% | +109.1% | +4.0% | -16.1% | +1.8% | +228.3% | +48.1% | +15.3% | +10.7% | -4.2% | -12.7% | +24.4% | +11.3% | +24.9% | -18.9% | +15.0% | +5.9% | +26.6% | +23.9% | +46.4% | -10.4% | -16.0% | +13.6% | +37.3% | +7.6% | – | |
| – | +0.0% | +39.3% | +28.9% | -51.2% | -1.8% | +86.3% | +14.5% | +2.0% | +6.6% | +505.3% | -41.6% | +28.5% | +2.8% | +78.9% | -18.1% | -8.4% | -11.4% | +37.4% | +6.3% | +41.3% | -17.0% | -15.5% | +48.2% | -13.7% | -12.8% | +5.4% | -1.6% | +13.9% | +23.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +100.0% | +0.0% | +3,700.0% | +114.5% | +54.6% | +27.4% | -82.9% | +2,183.6% | -100.0% | – | – | +0.0% | +300.0% | +166.7% | -43.8% | +5.6% | +5.3% | -20.0% | -6.3% | +33.3% | -25.0% | -13.3% | +15.4% | +80.0% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -141.6% | – | – | -1,231.1% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -195.6% | – | +2.7% | -92.1% | +0.0% | +352,466.7% | -99.7% | -346.9% | – | – | +2,361.3% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -141.6% | – | – | -1,231.1% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -140.1% | – | – | -974.4% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.